Home › NDC Lookup › RxCUI directory › RxCUI 421299

Glycerin 1200 MG Rectal Suppository — RxCUI 421299

RxNorm drug concept · Semantic clinical drug
RxCUI 421299 Semantic clinical drug · SCD ● Current RxNorm concept 7 FDA products 10 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI421299
Official nameGlycerin 1200 MG Rectal Suppository
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asglycerin 1.2 GM Rectal Suppository; glycerin 1.2 GM Pediatric Rectal Suppository; glycerin 82.5 % Pediatric Rectal Suppository
FDA products mapped7
Package NDCs mapped10
Reported Medicaid activity (SDUD)5,378 prescriptions · 21 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

🕸️ Concept Web — How Glycerin 1200 MG Rectal Suppository Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Glycerin 1200 MG Rectal Suppository RxCUI 421299

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Glycerin 4910
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Sani-Supp 1251053
  3. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Glycerin Rectal Suppository 372337
    • Glycerin Rectal Product 1156856
    • Glycerin Rectal Suppository [Sani-Supp] 1251055
    • Sani-Supp Rectal Product 1251056
    • Rectal Suppository 316978
    • Rectal Product 1151127
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Glycerin 1200 MG 440289
    • Glycerin 1200 MG Rectal Suppository [Sani-Supp] 1251062
    • Glycerin 1200 MG [Sani-Supp] 1251061

Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Glycerin 1200 MG SCDC · 440289
  • Glycerin Rectal Suppository SCDF · 372337
  • Glycerin Rectal Product SCDG · 1156856

Brand-Name Concepts

  • Glycerin 1200 MG Rectal Suppository [Sani-Supp] SBD · 1251062
  • Glycerin 1200 MG [Sani-Supp] SBDC · 1251061
  • Glycerin Rectal Suppository [Sani-Supp] SBDF · 1251055
  • Sani-Supp Rectal Product SBDG · 1251056
  • Sani-Supp BN · 1251053

📦 FDA Products & Package NDCs

7 products · 10 package NDCs
10 package NDCs map to RxCUI 421299 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
46122-0222-63 25 SUPPOSITORY in 1 JAR (46122-222-63) Glycerin Amerisource Bergen/Good Neighbor Pharmacy 2013-09-12
52316-0724-25 25 SUPPOSITORY in 1 JAR (52316-724-25) Glycerin DSC Laboratories Inc. 2012-08-15
57237-0326-21 2 BLISTER PACK in 1 CARTON (57237-326-21) / 6 SUPPOSITORY i... Glycerin Children Rising Pharma Holdings, Inc. 2023-08-24
57237-0326-52 5 BLISTER PACK in 1 CARTON (57237-326-52) / 5 SUPPOSITORY i... Glycerin Children Rising Pharma Holdings, Inc. 2023-08-24
57237-0338-21 2 BLISTER PACK in 1 CARTON (57237-338-21) / 6 SUPPOSITORY i... Proctozone-G Rising Pharma Holdings, Inc. 2025-07-31
57237-0338-52 5 BLISTER PACK in 1 CARTON (57237-338-52) / 5 SUPPOSITORY i... Proctozone-G Rising Pharma Holdings, Inc. 2025-07-31
72701-0105-12 2 BLISTER PACK in 1 CARTON (72701-105-12) / 6 SUPPOSITORY i... Bliss GVS Children Bliss GVS Pharma Limited 2020-01-20
72701-0105-25 5 BLISTER PACK in 1 CARTON (72701-105-25) / 5 SUPPOSITORY i... Bliss GVS Children Bliss GVS Pharma Limited 2020-01-20
83324-0285-25 25 SUPPOSITORY in 1 JAR (83324-285-25) Glycerin Chain Drug Marketing Association Inc. 2025-04-24
84415-0041-50 50 POUCH in 1 CARTON (84415-041-50) / 1 SUPPOSITORY in 1 PO... Glycerin Everpharm LLC 2026-06-16
Observed labelers: Rising Pharma Holdings, Inc. (4) · Bliss GVS Pharma Limited (2) · Amerisource Bergen/Good Neighbor Pharmacy (1) · Chain Drug Marketing Association Inc. (1) · DSC Laboratories Inc. (1) · Everpharm LLC (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

💲 Pricing (NADAC)

NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per ea · median
$0.0998
Range $0.0998–$0.0998 · middle 50% $0.0998–$0.0998 · 5 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.